T-cell receptor α chain germline gene polymorphisms in multiple sclerosis

Neurology

Volumn 42, Issue 1, 1992, Pages 80-84

  Hillert, Jan ^a,b   Leng, Chunmao ^a,b   Olerup, Olle ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Division of Clinical Immunology   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; T LYMPHOCYTE RECEPTOR GENE;

ALLELES; CHRONIC DISEASE; GENOTYPE; HAPLOTYPES; HLA-DR2 ANTIGEN; HUMAN; MULTIPLE SCLEROSIS; POLYMORPHISM (GENETICS); POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECURRENCE; SUPPORT, NON-U.S. GOV'T;

EID: 0026564544     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.42.1.80     Document Type: Article

References (39)

1. McFarland HF, Greenstein J, McFarlin DE, Eldridge R, Xu X, Krebs H. Family and twin studies in multiple sclerosis. Ann NY Acad Sci 1984;436:118-124.
2. Ebers GC, Bulman DE, Sadovnik AD, et al. A population- based study of multiple sclerosis in twins. N Engl J Med 1986;315:1638-1642.
3. Jersild C, Fog T, Hansen GS, Thomsen M, Svejgaard A, Dupont B. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 1972;2:1221-1225.
4. Marcadet A, Massart C, Semana G, et al. Association of class II HLA-DQI3 chain DNA restriction fragments with multiple sclerosis. Immunogenetics 1985;22:93-96.
5. Olerup O, Hillert J, Fredrikson S, et al. Primarily chronic progressive and relapsing remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989;86:7113-7117.
6. Ho H-Z, Tiwari JL, Haile RW, Terasaki PI, Morton NE. HLA-linked and unlinked determinants of multiple sclerosis. Immunogenetics 1982;15:509-517.
7. Ebers GC, Paty DW, Stiller CR, Nelson RF, Seland TP, Larsen B. HLA-typing in multiple sclerosis sibling pairs. Lancet 1982;1:88-90.
8. Bertrams J, Opferkuch W, Grosse-Wilde H, Luboldt W, Schuppien W, Kuwert E. C2 hypocomplementemia in multiple sclerosis. Lancet 1976;2:1358-1359.
9. Stewart GJ, Basten A, Kirk RL. Strong linkage between HLA-Dw2 and BfS in multiple sclerosis and the normal population. Tissue Antigens 1979;14:86-97.
10. Schroder R, Zander H, Andreas A, Hauff G. Multiple sclerosis: immunogenetic analysis of sib-pair double case families. II. Studies on the association of multiple sclerosis with C2, C4, Bf, C3, C6 and Glo polymorphism. Immunobiology 1983;164:160-170.
11. Pandey JP, Goust JM, Sailer JP, Fudenberg HH. Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis. J Clin Invest 1981;67:1797-1800.
12. Propert DN, Bernard CCA, Simons MJ. Gm allotypes and multiple sclerosis. J Immunogenet 1982;9:359-361.
13. Gaiser C, Johnson MJ, de Lange G, Rassenti L, Cavalli-Sforza LL, Steinman L. Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism. J Clin Invest 1987;79:309-313.
14. Hoover ML, Angelini G, Ball E, et al. HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harbor Symp Quant Biol 1986;51:803-809.
15. Demaine A, Welsh K, Hawe B, Farid N. Polymorphism of the T cell receptor fi-chain in Graves disease. J Clin Endocrinol Metab 1987;65:643-646.
16. Ito M, Tanimoto M, Kamura H, et al. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor 13-chain gene with Graves disease and Hashimoto’s thyroiditis. J Clin Endocrinol Metab 1989;69:100-104.
17. Martell M, Marcadet A, Strominger J, Dausset J, Cohen D. Les genes a du recepteur des cellules T: une possible implication dans la susceptibilite genetique a la sclerose en plaques. C R Acad Sci [III] 1987;304:105-110.
18. Oksenberg JR, Sherritt M, Begovic AB, et al. T-cell receptor Va and Ca alleles associated with multiple sclerosis and myasthenia gravis. Proc Natl Acad Sci USA 1989;86:988- 992.
19. Beall SS, Concannon P, Charmley P, et al. The germline repertoire of T cell receptor 13-chain genes in patients with chronic progressive multiple sclerosis. J Neuroimmunol 1989;21:59-66.
20. Fugger L, Sandberg-Wollheim M, Morling N, Ryder LP, Svejgaard A. The germline repertoire of T-cell receptor 13 chain genes in patients with relapsing/remitting multiple sclerosis or optic neuritis. Immunogenetics 1990;31:278-280.
21. Hillert J, Leng C, Olerup O. No association with germline T cell receptor 13-chain gene alleles or haplotypes in Swedish patients with multiple sclerosis. J Neuroimmunol 1991;31:141-147.
22. Schumacher G, Beebe B, Kibler R, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965;122:552-568.
23. Yanagi Y, Chan B, Chin M, Minden M, Mak T. Analysis of cDNA clones specific for human T cells and the a and 13 chains of the T-cell receptor heterodimer from a human T cell line. Proc Natl Acad Sci USA 1985;82:3430-3434.
24. Sim GY, Yague J, Nelson J, et al. Primary structure of human T-cell receptor a-chain. Nature 1984;312:771-775.
25. Carlsson B, Wallin J, Bohme J, Moller E. HLA-DR-DQ haplotypes defined by restriction fragment length analysis: correlation to serology. Hum Immunol 1987;20:95-113.
26. Bidwell JL, Bidwell EA, Laundy GJ, Klouda PT, Bradley EA. Allogenotypes defined by short DQa and DQ13 cDNA probes correlate with and define splits of HLA-DQ serological specificities. Mol Immunol 1987;24:513-522.
27. Bidwell JL. DNA-RFLP-analysis and genotyping of HLA-DR and -DQ antigens. Immunol Today 1988;9:18-23.
28. Robinson MA, Kindt TJ. Genetic recombination within the human T-cell receptor a-chain gene complex. Proc Natl Acad Sci USA 1987;84:9089-9093.
29. Gao X, Ball EJ, Dombrauski L, et al. Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am J Med 1988;85:14-16.
30. Demaine AG, Vaughan RW, Taube DH, Welsh KI. Association of membraneous nephropathy with T-cell receptor constant 13 chain and immunoglobulin heavy chain switch region polymorphisms. Immunogenetics 1988;27:19- 23.
31. Seboun E, Robinson MA, Doolittle TA, Ciulla TA, Kindt TJ, Hauser SL. A susceptibility locus for multiple sclerosis is linked to the T cell receptor 13 chain complex. Cell 1989;57:1095-1100.
32. Millward BA, Welsh KI, Leslie RDG, Pyke DA, Demaine AG. T cell receptor beta chain polymorphisms are associated with insulin-dependent diabetes. Clin Exp Immunol 1987;70:152-157.
33. Ito M, Tanimoto M, Kamura H, et al. Association of HLA-DR phenotypes and T-lymphocyte-receptor 13-chain-region RFLP with IDDM in Japanese. Diabetes 1988;37:1633-1636.
34. Reijonen H, Silvennoinen-Kassinen S, Ilonen J, Knip M. Lack of association of T cell receptor beta-chain constant region polymorphism with insulin-dependent diabetes mellitus in Finland. Clin Exp Immunol 1990;81:396-399.
35. Weetman AP, So AK, Roe C, Walport MJ, Foroni L. T-cell receptor a chain V region polymorphism linked to primary autoimmune hypothyroidism but not to Graves disease. Hum Immunol 1987;20:167-173.
36. Wallin J, Hillert J, Olerup O, Carlsson B, Strom H. Association of rheumatoid arthritis with a dominant DR1/Dw4/Dwl4 sequence motif, but not with T-cell receptor 13 chain gene alleles or haplotypes. Arthritis Rheum (in press).
37. Posnett DN. Allelic variations of human TCR V gene products. Immunol Today 1990;11:368-373.
38. Wong DW, Bentwich Z, Martinez-Tarquino C, et al. Nonlinkage of the T cell receptor a, 13 and gamma genes to systemic lupus erythematosus in multiplex families. Arthritis Rheum 1989;31:1371-1376.
39. Sheehy MJ, Meske LM, Emler CA, et al. Allelic T-cell receptor a complexes have little or no influence on susceptibility to type 1 diabetes. Hum Immunol 1989;26:261-271.